Teva 和 Alvotech 推出首款可互换高浓度产品。 Teva and Alvotech launch the first interchangeable high-concentration.

Teva Pharmaceuticals 和 Alvotech 宣布在美国推出 SIMLANDI（阿达木单抗-ryvk），这是首个可互换的高浓度、无柠檬酸盐的 Humira 生物仿制药。 Teva Pharmaceuticals and Alvotech have announced the availability of SIMLANDI (adalimumab-ryvk), the first interchangeable high-concentration, citrate-free biosimilar to Humira, in the US. 它适用于治疗各种自身免疫性疾病，如类风湿性关节炎、银屑病关节炎、克罗恩病、溃疡性结肠炎、斑块状银屑病、化脓性汗腺炎和葡萄膜炎。 It is indicated for the treatment of various autoimmune conditions like rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.